Lyell Immunopharma, Inc. (LYEL)
12.09
-0.79
(-6.13%)
USD |
NASDAQ |
Sep 10, 14:19
Lyell Immunopharma Price : 12.09 for Sept. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 13.52 | 13.82 | 12.71 | 12.88 | 101566.0 |
| Sep 08, 2026 | 14.12 | 14.13 | 13.37 | 13.53 | 83002.00 |
| Sep 04, 2026 | 14.29 | 14.68 | 13.92 | 14.37 | 54065.00 |
| Sep 03, 2026 | 15.11 | 15.14 | 14.19 | 14.32 | 79053.00 |
| Sep 02, 2026 | 14.49 | 14.97 | 14.25 | 14.96 | 56859.00 |
| Sep 01, 2026 | 14.14 | 14.84 | 14.00 | 14.52 | 67015.00 |
| Aug 31, 2026 | 14.51 | 14.71 | 14.14 | 14.32 | 62771.00 |
| Aug 28, 2026 | 14.56 | 14.78 | 14.06 | 14.53 | 78122.00 |
| Aug 27, 2026 | 14.67 | 15.02 | 14.33 | 14.61 | 88377.00 |
| Aug 26, 2026 | 15.34 | 15.41 | 14.61 | 14.80 | 87778.00 |
| Aug 25, 2026 | 15.02 | 15.68 | 14.92 | 15.49 | 102998.0 |
| Aug 24, 2026 | 15.30 | 15.49 | 14.46 | 14.74 | 73238.00 |
| Aug 21, 2026 | 15.54 | 16.16 | 15.20 | 15.53 | 104915.0 |
| Aug 20, 2026 | 15.59 | 16.02 | 14.52 | 15.35 | 207668.0 |
| Aug 19, 2026 | 16.02 | 17.15 | 15.66 | 15.76 | 171047.0 |
| Aug 18, 2026 | 13.54 | 15.81 | 13.46 | 15.79 | 311000.0 |
| Aug 17, 2026 | 13.86 | 13.93 | 13.39 | 13.55 | 132564.0 |
| Aug 14, 2026 | 13.77 | 14.02 | 13.42 | 13.95 | 106070.0 |
| Aug 13, 2026 | 14.20 | 14.41 | 13.70 | 13.74 | 89101.00 |
| Aug 12, 2026 | 14.77 | 15.01 | 14.07 | 14.17 | 98146.00 |
| Aug 11, 2026 | 14.33 | 15.52 | 14.32 | 14.88 | 134518.0 |
| Aug 10, 2026 | 14.50 | 15.08 | 14.09 | 14.33 | 203106.0 |
| Aug 07, 2026 | 14.00 | 15.09 | 13.94 | 14.71 | 111168.0 |
| Aug 06, 2026 | 14.01 | 15.62 | 13.85 | 14.21 | 362842.0 |
| Aug 05, 2026 | 13.50 | 13.98 | 13.20 | 13.45 | 484688.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 82.79 |
| Oncolytics Biotech, Inc. | 0.7818 |
| Sangamo Therapeutics, Inc. | 0.155 |
| Sarepta Therapeutics, Inc. | 20.29 |
| Anixa Biosciences, Inc. | 2.77 |
Price Related Metrics
| PS Ratio | 9488.34 |
| Price to Book Value | 1.210 |
| Earnings Yield | -97.34% |
| Market Cap | 282.87M |